BridgeMD
New treatment option for Healthy Adults
Official title A Study to Learn About mRNA Vaccines Against Influenza in Adults
ClinicalTrials.gov ID: NCT07431853
What this study is testing
What is Vaccine Candidate #1?
Vaccine Candidate #1 is an investigational medicine, being studied as a potential treatment for healthy adults.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to learn about safety in participants taking the study vaccine (mRNA-based vaccine) and the ability of the study vaccine to trigger the body's immune response, targeting the flu virus (influenza virus). This study is seeking healthy participants 18 years of age or older.
- Phase 2: a mid-size study of how well it works
- Time commitment: about 6 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Healthy and medically stable participants who are determined by medical history, physical examination (if clinically required), and clinical judgment...
You likely can't join if
- Tested positive for influenza ≤5 months (150 days) prior to Visit 1 (Day 1).
- Vaccination with any investigational or licensed influenza vaccine ≤5 months (150 days) before Visit 1 (Day 1).
- Receipt of antiviral therapies for influenza (eg, Tamiflu) ≤5 months (150 days) prior to Visit 1 (Day 1).
The study team makes the final eligibility decision.
Where it's taking place
- Mobile, Alabama, United States
- Walnut Creek, California, United States
- Milford, Connecticut, United States
- Washington D.C., District of Columbia, United States
- Hialeah, Florida, United States
- Miami Lakes, Florida, United States
- Stockbridge, Georgia, United States
- Honolulu, Hawaii, United States
- Kansas City, Missouri, United States
- Rochester, New York, United States
- Philadelphia, Pennsylvania, United States
- Mesquite, Texas, United States
- Tomball, Texas, United States
- Salt Lake City, Utah, United States
- Charlottesville, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mobile, Alabama, United States; Walnut Creek, California, United States; Milford, Connecticut, United States; Washington D.C., District of Columbia, United States; Hialeah, Florida, United States; Miami Lakes, Florida, United States and 9 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.